Suzhou Biosynthetica Co.
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- $14M
Investors
- 3
About Suzhou Biosynthetica Co.
, Ltd., Ltd. operates out of Suzhou, China, specializing in synthetic biology to produce essential compounds for pharmaceuticals and nutritional products., Ltd. specializes in the development and production of nucleotide-related raw materials and active pharmaceutical ingredients (APIs) through innovative synthetic biology techniques. The company focuses on creating novel microorganisms that efficiently produce key compounds such as nucleotides, which are essential in pharmaceuticals, nutritional supplements, and various food products. Their offerings include L-Histidine, L-Carnosine, and other amino acid derivatives, which are utilized in health products, flavoring agents, and feed additives. The firm serves a diverse clientele, including pharmaceutical companies, nutritional supplement manufacturers, and food industry players, primarily in Asian markets, while also targeting expansion into North America and Europe.Suzhou Biosynthetica's revenue model is primarily based on B2B transactions, facilitating partnerships with various companies in the pharmaceutical and nutritional sectors. The company engages in direct sales of its products, including flagship offerings like L-Histidine and other specialized amino acids, to its commercial clients. The transaction structure typically involves bulk orders and long-term supply agreements, allowing businesses to integrate these ingredients into their own product lines. Pricing is determined according to the specific needs of clients and the scale of production, accommodating both small-scale and large-scale operations., Ltd. The company plans to expand its product offerings and aims to penetrate new markets, specifically targeting North America and Europe for growth by 2028.
Who invested in Suzhou Biosynthetica Co.
3 investors across 1 round
See all investors in Suzhou Biosynthetica Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 2, 2026
Amount
$14M
Investors
Questions about Suzhou Biosynthetica Co.
Who invested in Suzhou Biosynthetica Co.?
Suzhou Biosynthetica Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Suzhou Biosynthetica Co. raised?
Suzhou Biosynthetica Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Suzhou Biosynthetica Co. last raise money?
Suzhou Biosynthetica Co.'s most recent round on record is a Series A, in Jan 2026.
What does Suzhou Biosynthetica Co. do?
Suzhou Biosynthetica Co. is a biotechnology company.
Where is Suzhou Biosynthetica Co. headquartered?
Suzhou Biosynthetica Co. is headquartered in Suzhou, China.
Which VCs invest in companies like Suzhou Biosynthetica Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Suzhou Biosynthetica Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Suzhou Biosynthetica Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.